Author

Christopher A. Naranjo

Koch Institute for Integrative Cancer Research At MIT

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genomics· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:protein design· 1 Assay:protein sequence· 1 Organism:rat· 1 Research Focus:variant calling· 1

Frequent Co-Authors

John Christopher LoveiD· 2 shared Sergio A. Rodriguez‐AponteiD· 2 shared Aiquan ChangiD· 1 shared Andrew M. BiedermanniD· 1 shared Ashley A. LemniosiD· 1 shared Brittany L. HartwelliD· 1 shared Carmen Martin-AlonsoiD· 1 shared Célia Lebas· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

John Christopher LoveORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

An intravenous DNA-binding priming agent protects cell-free DNA and improves the sensitivity of liquid biopsies

Shervin Tabrizi, Carmen Martin-Alonso, Kan Xiong, Timothy Blewett, Sainetra Sridhar, Zhenyi An, Sahil Patel, Sergio A. Rodriguez‐Aponte, Christopher A. Naranjo, Shih‐Ting Wang, Douglas Shea, Todd R. Golub, Sangeeta N. Bhatia, Viktor A. Adalsteinsson, John Christopher Love

A DNA-binding agent increases cfDNA levels in blood, improving ctDNA detection and cancer sensitivity in mice.

bioRxiv · Jan 13, 2023 · PreprintGenomics

Engineered SARS-CoV-2 receptor binding domain improves immunogenicity in mice and elicits protective immunity in hamsters

Neil C. Dalvie, Sergio A. Rodriguez‐Aponte, Brittany L. Hartwell, Lisa H. Tostanoski, Andrew M. Biedermann, Laura E. Crowell, Kawaljit Kaur, Ozan S. Kumru, Lauren P. Carter, Jingyou Yu, Aiquan Chang, Katherine McMahan, Thomas Courant, Célia Lebas, Ashley A. Lemnios, , John Christopher Love

This paper describes an engineered SARS-CoV-2 RBD variant that shows improved immunogenicity in mice and protective immunity in hamsters.

bioRxiv · Mar 3, 2021 · PreprintMolecular Biology